Article
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.
International journal of cancer - 1 Nov 2009
Zieger Karsten, Marcussen Niels, Borre Michael, Ørntoft Torben F, Dyrskjøt Lars
Abstract excerpt
Bladder cancer develops through different pathways, provisionally entitled "papillary" and "invasive." Carcinoma in situ (CIS) is thought to be the precursor of invasive bladder cancer. However, little is known about chromosomal alterations of these clinically important lesions, and the relationship between chromosomal alterations and the different pathways. We laser-microdissected 12 CIS and 4 dysplasia samples...
Topics
- Carcinoma in Situ
- Chromosome Aberrations
- Gene Dosage
- Gene Expression Profiling
- Humans
- Loss of Heterozygosity
- Mutation
- Polymerase Chain Reaction
- Polymorphism, Single Nucleotide
- Receptor, Fibroblast Growth Factor, Type 3
- Urinary Bladder Neoplasms
